A clinical trial to see whether outcomes in Hodgkins Lymphoma can be improved by using increased intensity therapy in interim PET scan positive patients
Phase 2
Completed
- Conditions
- Health Condition 1: null- Advanced Hodgkins Lymphoma (Stage IIb, III, IV)Health Condition 2: C819- Hodgkin lymphoma, unspecifiedHealth Condition 3: C819- Hodgkin lymphoma, unspecified
- Registration Number
- CTRI/2012/06/002741
- Lead Sponsor
- Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Newly diagnosed patients of Advanced Hodgkins lymphoma- stages IIB, III and IV
Exclusion Criteria
Pregnancy, Lactating Mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of a strategy of â??Response adaptedâ?? therapy in advanced HL patients using PET CT scan after 2 cycles of standard ABVD chemotherapy.Timepoint: 1 year
- Secondary Outcome Measures
Name Time Method To prospectively assess the safety and tolerability of esc-BEACOPP regimen in Indian patientsTimepoint: 6 months